KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 130 | 1 | 128 | −1 |
| Shares | 55.2M | 80.4K | 54.9M | −189.1K (−0.3%) |
| Value | $467.4M | $681.4K | $633.7M | +$166.9M (+35.8%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 753,752 | $8.70M | 1.03% |
| Schonfeld Strategic Advisors LLC | 581,746 | $6.71M | 0.05% |
| Millennium Management LLC | 198,205 | $2.29M | 0.00% |
| Diadema Partners LP | 135,509 | $1.56M | 1.25% |
| AQR Capital Management LLC | 55,975 | $646.0K | 0.00% |
| F/M Investments LLC | 50,097 | $578.1K | 0.02% |
| Engineers Gate Manager LP | 25,842 | $298.2K | 0.01% |
| Stonepine Capital Management, LLC | 21,550 | $248.7K | 0.29% |
| Ieq Capital, LLC | 10,915 | $126.0K | 0.00% |
| Quarry LP | 8,400 | $96.9K | 0.03% |
| US Bancorp | 570 | $6.58K | 0.00% |
| Skopos Labs, Inc. | 347 | $4.00K | 0.00% |
| Quadrant Capital Group LLC | 337 | $3.89K | 0.00% |
| Lindbrook Capital, LLC | 265 | $3.06K | 0.00% |
| Farther Finance Advisors, LLC | 196 | $2.19K | 0.00% |
| Larson Financial Group LLC | 144 | $1.66K | 0.00% |
| True Wealth Design, LLC | 144 | $1.66K | 0.00% |
| CIBC Private Wealth Group, LLC | 160 | $1.65K | 0.00% |
| Coldstream Capital Management Inc | 69 | $797 | 0.00% |
| Allworth Financial LP | 31 | $400 | 0.00% |
| Stephens Consulting, LLC | 30 | $347 | 0.00% |
| Nuveen, LLC | 37,321 | – | – |
| Capital Performance Advisors LLP | 3,845 | – | – |
Sold out (24)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Boxer Capital Management, LLC | 1,590,000 | $13.5M |
| Readystate Asset Management LP | 315,700 | $2.67M |
| Citadel Advisors LLC | 136,493 | $1.16M |
| Qube Research & Technologies Ltd | 126,132 | $1.07M |
| Zimmer Partners, LP | 95,704 | $810.6K |
| Jane Street Group, LLC | 69,397 | $587.8K |
| Simplex Trading, LLC | 35,125 | $297.0K |
| XTX Topco Ltd | 31,573 | $267.4K |
| Two Sigma Advisers, LP | 22,822 | $193.3K |
| Advisor Group Holdings, Inc. | 20,804 | $176.2K |
| Group One Trading, L.P. | 20,227 | $171.3K |
| Quest Partners LLC | 17,700 | $149.9K |
| SG Americas Securities, LLC | 14,508 | $123.0K |
| Two Sigma Investments, LP | 13,463 | $114.0K |
| Nebula Research & Development LLC | 11,579 | $98.1K |
| EntryPoint Capital, LLC | 11,509 | $97.5K |
| Syon Capital LLC | 10,993 | $93.1K |
| Profund Advisors LLC | 10,762 | $91.2K |
| Graham Capital Management, L.P. | 10,479 | $88.8K |
| Algert Global LLC | 10,360 | $87.7K |
| American Century Companies Inc | 10,072 | $85.3K |
| Aquatic Capital Management LLC | 5,188 | $43.9K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,164 | $9.86K |
| R Squared Ltd | 110 | $932 |
Not filed for Q1 2025 yet (1)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 80,443 | $681.4K |